The Journal of Bone and Joint Surgery (American). 2009;91:79-86.
doi:10.2106/JBJS.I.00521
© 2009 The Journal of Bone and Joint Surgery, Inc.
Osteoporosis Disease Management: What Every Orthopaedic Surgeon Should Know
Richard M. Dell, MD, CCD1,
Denise Greene, FNP, CCD1,
David Anderson, MD, CCD2 and
Kathy Williams, MSG2
1 Kaiser Downey, 9353 East Imperial Highway, Downey, CA 90242. E-mail address for R.M. Dell: Richard.M.Dell@kp.org. E-mail address for D. Greene: Denise.F1.Greene@kp.org
2 Department of Orthopedics, Kaiser Fontana, 9985 Sierra Avenue, Fontana, CA 92335
| The first 150 words of the full text of this article appear below. |
 |
Introduction
|
|---|
According to recent information from the National Osteoporosis Foundation1 and the Office of the Surgeon General2, osteoporosis is a major medical problem. The disease currently affects 8 million women and 2 million men in the United States. An additional 34 million Americans have low bone mass. Each year, an estimated 1.5 million individuals in the United States experience a fragility fracture secondary to osteoporosis, resulting in an annual cost of 18 billion dollars. With the rapidly aging U.S. population, the problem of osteoporosis is now reaching epidemic proportions. There are 75 million baby boomers entering the stage in their lives when they are most at risk for osteoporosis. One-half of all women and one-third of all men will sustain a fragility fracture during their lifetime.
There is a huge cost associated with osteoporosis in terms of morbidity, mortality, and the financial impact on society. The most devastating complication of . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
|